foxo4 dri cancer The disordered p53 transactivation domain is the target of and the senolytic compound FOXO4-DRI Peptide inhibitors targeting FOXO4-p53 interactions
Pay in 4 interest-free payments of $7.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17





























